Progression of a series of patients with relapsing-remitting multiple sclerosis treated for 7 years with natalizumab using the “no evidence of disease activity” parameter

1. Pato Pato, A.
2. Costa Arpín, E.
3. Rodríguez Regal, A.
4. Rodríguez Constenla, I.
5. Cimas Hernando, I.
6. Muñoz Pousa, I.
7. Naya Ríos, L.
8. Lorenzo González, J.R.
9. Amigo Jorrín, M.C.
10. Prieto González, J.M.

Exportar

Exportar

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Exportar

×

Non se pode exportar o documento porque pertence a outro portal.

Texto completo

lock_openTexto completo externo

DOI: 10.1016/J.NRL.2018.02.003 GOOGLE SCHOLAR lock_openAcceso aberto editor

Obxectivos de Desenvolvemento Sustentable

• 

Fonte de datos: Scopus